Last week the U.S. Food and Drug Administration approved the first treatment ever for advanced stomach cancer that has not responded to chemotherapy. Charles Fuchs, professor of medicine at the Dana-Farber Cancer Institute, is the lead investigator of the medication, called Cyramza.
